Gujarat Themis Biosyn Limited (GUJTHEM) reports Q2 FY27 revenue up 12% YoY, new fermentation facility commissioned.
Zydus Lifesciences Limited (ZYDUSLIFE) announces the closure of USFDA inspection at LiqMeds, UK with 4 observations.
Alkem Laboratories Limited (ALKEM) reports 14% revenue growth in Q2FY27, with strong performance in both domestic and international segments.
Suven Life Sciences Limited (SUVEN) to present seven scientific posters at Neuroscience 2026, showcasing CNS drug discovery.
Lupin Limited (LUPIN) announces the European launch of its biosimilar Ranibizumab, expanding access to retinal disease treatment.
Lotus Eye Hospital and Institute Limited (LOTUSEYE) reports a 36% revenue growth in Q2 FY 2026-27, with net profit rising to ¥43.95 lakh.
Jubilant Pharmova Limited (JUBLPHARMA) announces preliminary Phase 1 clinical data for JBI-802 presented at 68th ASH Annual Meeting.
Morepen Laboratories Limited (MOREPENLAB) launches Desloratadine Tablets in U.S. prescription market, expanding its pharmaceutical capabilities.
Cohance Lifesciences Limited (COHANCE) Q2 FY27 investor presentation highlights sequential recovery, revenue up 13% QoQ.
Fermenta Biotech Limited (FERMENTA) reports Q2 FY27 results with revenue up 8% QoQ to INR 135.8 crore and EBITDA up 3% QoQ.